Filter News
Area of Research
- (-) Neutron Science (106)
- (-) Supercomputing (76)
- Advanced Manufacturing (22)
- Biology and Environment (29)
- Building Technologies (1)
- Clean Energy (149)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (8)
- Electricity and Smart Grid (3)
- Functional Materials for Energy (1)
- Fusion and Fission (10)
- Fusion Energy (3)
- Isotope Development and Production (1)
- Isotopes (4)
- Materials (125)
- Materials Characterization (1)
- Materials for Computing (19)
- Materials Under Extremes (1)
- National Security (37)
- Nuclear Science and Technology (16)
- Quantum information Science (2)
- Sensors and Controls (1)
- Transportation Systems (1)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (10)
- (-) Cybersecurity (9)
- (-) Frontier (29)
- (-) Grid (5)
- (-) Machine Learning (16)
- (-) Materials Science (33)
- (-) Neutron Science (101)
- (-) Polymers (3)
- (-) Space Exploration (5)
- Advanced Reactors (2)
- Artificial Intelligence (39)
- Big Data (20)
- Bioenergy (13)
- Biology (14)
- Biomedical (25)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (17)
- Composites (1)
- Computer Science (98)
- Coronavirus (17)
- Critical Materials (3)
- Decarbonization (7)
- Energy Storage (14)
- Environment (28)
- Exascale Computing (22)
- Fossil Energy (1)
- Fusion (2)
- High-Performance Computing (39)
- Isotopes (1)
- Materials (28)
- Mathematics (1)
- Microscopy (8)
- Molten Salt (1)
- Nanotechnology (19)
- National Security (8)
- Net Zero (1)
- Nuclear Energy (7)
- Partnerships (1)
- Physics (16)
- Quantum Computing (19)
- Quantum Science (29)
- Security (6)
- Simulation (14)
- Software (1)
- Summit (42)
- Sustainable Energy (11)
- Transportation (10)
Media Contacts
In 2023, the National School on X-ray and Neutron Scattering, or NXS, marked its 25th year during its annual program, held August 6–18 at the Department of Energy’s Oak Ridge and Argonne National Laboratories.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
ORNL hosted its annual Smoky Mountains Computational Sciences and Engineering Conference in person for the first time since the COVID-19 pandemic.
As Frontier, the world’s first exascale supercomputer, was being assembled at the Oak Ridge Leadership Computing Facility in 2021, understanding its performance on mixed-precision calculations remained a difficult prospect.
The Department of Energy’s Oak Ridge National Laboratory hosted its Smoky Mountains Computational Science and Engineering Conference for the first time in person since the COVID pandemic broke in 2020. The conference, which celebrated its 20th consecutive year, took place at the Crowne Plaza Hotel in downtown Knoxville, Tenn., in late August.
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
Neutron experiments can take days to complete, requiring researchers to work long shifts to monitor progress and make necessary adjustments. But thanks to advances in artificial intelligence and machine learning, experiments can now be done remotely and in half the time.
Outside the high-performance computing, or HPC, community, exascale may seem more like fodder for science fiction than a powerful tool for scientific research. Yet, when seen through the lens of real-world applications, exascale computing goes from ethereal concept to tangible reality with exceptional benefits.
A group at the Department of Energy's Oak Ridge National Laboratory made a difference for local youth through hands-on projects that connected neutron science and engineering intuitively.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.